Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)

6 Months Ended

Jun. 30, 2023

The following tables set forth the computation of basic and diluted net loss per share of common stock for the three and six months ended June 30, 2023 and June 30, 2022 (in thousands, except share and per share amounts):


	Three Months Ended June 30,
	2023		2022
Net loss	$	(8,193)	$	(12,987)
Weighted average shares	13,971,968		9,400,902
Basic and diluted net loss per share	$	(0.59)	$	(1.38)


	Six Months Ended June 30,
	2023		2022
Net loss	$	(18,148)	$	(35,038)
Weighted average shares	12,853,579		9,400,214
Basic and diluted net loss per share	$	(1.41)	$	(3.73)

Schedule of Anti-dilutive Securities

The following outstanding securities have been excluded from the computation of diluted weighted shares outstanding for the three and six months ended June 30, 2023 and 2022, as they could have been anti-dilutive:


	Three and Six Months Ended
	June 30,
	2023	2022
Stock options	1,849,229	1,379,570
Warrants on common stock1	4,136,990	366,990
Restricted Stock Units	—	—

1 The weighted average number of common shares outstanding includes the weighted average outstanding pre-funded warrants for the period because their exercise price is nominal. The weighted average shares outstanding for the three and six months ended June 30, 2023 include the weighted average effect of 525,909 and 321,096 pre-funded warrants, respectively. The weighted average shares outstanding for the three and six months ended June 30, 2022 included the weighted average effect of 114,007 pre-funded warrants.